carvedilol has been researched along with cyclic gmp in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Demura, H; Imaki, T; Matsuda, Y; Muraki, T; Naruse, K; Naruse, M; Seki, T; Tanabe, A; Yoshimoto, T | 1 |
| Kakihana, M; Ohtsuka, S; Sugishita, Y; Watanabe, H | 2 |
| Bassenge, E; Fink, B; Fink, N; Schwemmer, M | 1 |
| Funae, Y; Hirai, H; Minamiyama, Y; Nakahira, A; Okada, S; Sasaki, Y; Suehiro, S; Takemura, S | 1 |
| Barbagallo, F; Deng, B; Liu, Y; Reddy, GR; Shi, Q; Wang, Q; Wang, Y; Wei, W; West, TM; Xiang, YK; Xu, B | 1 |
2 trial(s) available for carvedilol and cyclic gmp
| Article | Year |
|---|---|
Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure.
Topics: Adrenergic Antagonists; Aged; Blood Flow Velocity; Blood Platelets; Blood Pressure; Carbazoles; Carvedilol; Chronic Disease; Cyclic GMP; Double-Blind Method; Doxazosin; Drug Hypersensitivity; Drug Therapy, Combination; Female; Follow-Up Studies; Forearm; Heart Failure; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Nitroglycerin; Propanolamines; Vasodilator Agents | 1998 |
Preventive effects of carvedilol on nitrate tolerance--a randomized, double-blind, placebo-controlled comparative study between carvedilol and arotinolol.
Topics: Adrenergic Antagonists; Adult; Aged; Blood Flow Velocity; Blood Platelets; Blood Pressure; Carbazoles; Carvedilol; Cyclic GMP; Double-Blind Method; Drug Hypersensitivity; Drug Therapy, Combination; Female; Follow-Up Studies; Forearm; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nitroglycerin; Propanolamines; Vasodilator Agents | 1998 |
4 other study(ies) available for carvedilol and cyclic gmp
| Article | Year |
|---|---|
Potentiation of natriuretic peptide action by the beta-adrenergic blocker carvedilol in hypertensive rats: a new antihypertensive mechanism.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Carbazoles; Carvedilol; Cyclic GMP; Hypertension; Male; Propanolamines; Rats; Rats, Inbred SHR; Receptors, Atrial Natriuretic Factor; RNA, Messenger | 1998 |
Tolerance to nitrates with enhanced radical formation suppressed by carvedilol.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Ascorbic Acid; Blood Platelets; Calcium; Carbazoles; Carvedilol; Cyclic GMP; Dogs; Female; Male; Nitroglycerin; Nitroprusside; Platelet Aggregation; Propanolamines; Reactive Oxygen Species; Vasodilator Agents | 1999 |
Coadministration of carvedilol attenuates nitrate tolerance by preventing cytochrome p450 depletion.
Topics: Animals; Carbazoles; Carvedilol; Cell Adhesion Molecules; Cyclic GMP; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Drug Tolerance; Free Radicals; Male; Microfilament Proteins; Nitric Oxide; Nitroglycerin; Phosphoproteins; Propanolamines; Rats; Superoxides | 2010 |
Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Cardiotonic Agents; Carvedilol; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Heart Diseases; Male; Mice, Inbred C57BL; Mice, Knockout; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Rats; Receptors, Adrenergic, beta-1; Second Messenger Systems | 2021 |